Heart Failure: Finerenone and SGLT2 Inhibitor Study

We are investigating whether a combination of finerenone and an SGLT2 inhibitor can improve health outcomes for hospitalized heart failure patients. This study aims to see if this approach leads to better symptom relief and fewer hospital visits.

1-2 yearsConfirmation phase (III)No PlaceboCost ReimbursementPartially RemoteStandard MedicinesOralCardiologyInternal Medicine

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Jardiance
Jardiance is a medicine that helps lower blood sugar in adults with type 2 diabetes.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Canagliflozin Monohydrate
Canagliflozin monohydrate is a substance that helps lower blood sugar in people with type 2 diabetes.
Empagliflozin
Empagliflozin is a substance that helps lower blood sugar in people with type 2 diabetes by increasing sugar removal in the urine.
Finerenone
Finerenone is a substance that helps protect the kidneys and heart in adults with chronic kidney disease related to type 2 diabetes.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Empagliflozin Krka
Empagliflozin Polpharma
Empaglifozin

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Complexo Hospitalario Universitario A Coruna
Cardiology
A Coruña, Spain
Hospital Germans Trias I Pujol
Cardiology
Badalona, Spain
Hospital Universitario La Paz
Cardiology
Chamartín, Spain
Sponsor: Colorado Prevention Center
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.